MIGS has no lasting effect on anterior segment parameters

Article

Implantation of the Ex-PRESS miniature device has been found to have no lasting effects on anterior segment parameters, according to recently published data in the Journal of Glaucoma.

Implantation of the Ex-PRESS miniature device has been found to have no lasting effects on anterior segment parameters, according to recently published data in the Journal of Glaucoma.

The study led by Dr Na’ama Hammel (Department of Ophthalmology, Rabin Medical Center, Petah-Tiqva, Israel) analysed 19 eyes of 19 patients to evaluate if the Ex-PRESS miniature glaucoma implant surgery would affect corneal curvature and anterior segment parameters.

The team used the Pentacam rotating Scheimpflug camera (Oculus Inc.) to analyse the eyes preoperatively and then at 1 day, 1 week, 1 month and 3 months postoperatively to determine if there were any changes in parameters. Measurements were taken of the anterior and posterior corneal curvature, anterior and posterior corneal astigmatism, anterior chamber depth (ACD), anterior chamber volume (ACV) and anterior chamber angle before and after surgery.

One day after surgery and at 3 months post-op, the intraocular pressure (IOP) was found to reduce to a statistically significant level. The anterior corneal astigmatism and posterior corneal astigmatism increased, and the ACD and ACV both decreased on the first post-op day. However, at 3 months post-op these changes in anterior segment parameters were not found to be statistically significant.

For more detailed information please view the abstract here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.